Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.

David M Leistner, Steven Dietrich, Aslihan Erbay, Julia Steiner, Youssef Abdelwahed, Patrick T Siegrist, Matthias Schindler, Carsten Skurk, Arash Haghikia, David Sinning, Matthias Riedel, Ulf Landmesser, Barbara E Stähli

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2021;96(4):E439-E446

PMID: 32141669

Abstract

OBJECTIVES

This study sought to investigate the relation between left ventricular end-diastolic pressure (LVEDP) and outcomes in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS).

BACKGROUND

Risk stratification in ACS patients is important. Data on the role of LVEDP in the prognostication of ACS patients are scarce.

METHODS

A total of 1,410 patients undergoing PCI for ACS and with available data on LVEDP were divided according to LVEDP tertiles (lowest tertile: ≤13 mmHg, intermediate tertile: 14-20 mmHg, and highest tertile: >20 mmHg). The primary endpoint was all-cause mortality at a median follow-up of 246 [28-848] days.

RESULTS

Median LVEDP was 16 (11-22) mmHg. All-cause mortality was 2.8%, 4.5%, and 15.0% in the lowest, the intermediate, and the highest LVEDP tertile groups (p < .001), respectively. Belonging to the highest LVEDP tertile was associated with an increased risk of all-cause mortality (adjusted hazard ratio [HR] = 2.66, 95% confidence interval [CI] [1.30, 5.47], p = .008). By receiver operating characteristic curve analysis, the optimal cut-off value for predicting all-cause mortality was 20 mmHg (sensitivity 68.3%, specificity 72.5%). There was no differential effect of LVEDP on mortality in patients with and without LV dysfunction (interaction p = .23) or ST-elevation myocardial infarction as index ACS event (interaction p = .86).

CONCLUSIONS

In patients undergoing PCI for ACS, LVEDP was independently related with mortality. Hence, LVEDP should be incorporated into early risk stratification and clinical decision making of ACS patients.

© 2020 Wiley Periodicals, Inc.

Address: Department of Cardiology, Charité Berlin - University Medicine, Campus Benjamin Franklin, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.